Gut-derived peptide hormone receptor expression in the developing mouse hypothalamus
暂无分享,去创建一个
[1] Chathura Gunasekara,et al. Sex-specific epigenetic development in the mouse hypothalamic arcuate nucleus pinpoints human genomic regions associated with body mass index , 2022, Science advances.
[2] Ż. Kimber-Trojnar,et al. Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus , 2022, International journal of molecular sciences.
[3] Zeyun Li,et al. A GLP‐1/glucagon (GCG)/CCK2 receptors tri‐agonist provides new therapy for obesity and diabetes , 2022, British journal of pharmacology.
[4] G. Atella,et al. The model of litter size reduction induces long‐term disruption of the gut‐brain axis: An explanation for the hyperphagia of Wistar rats of both sexes , 2022, Physiological reports.
[5] P. Nathanielsz,et al. Dipeptidyl peptidase IV inhibition delays developmental programming of obesity and metabolic disease in male offspring of obese mothers , 2022, Journal of Developmental Origins of Health and Disease.
[6] C. Kappen,et al. Effects of Maternal Diabetes and Diet on Gene Expression in the Murine Placenta , 2022, Genes.
[7] H. Preissl,et al. Incretin hypersecretion in gestational diabetes mellitus , 2021, medRxiv.
[8] Mei Liu,et al. GIP-GIPR promotes neurite outgrowth of cortical neurons in Akt dependent manner. , 2020, Biochemical and biophysical research communications.
[9] Ming Li,et al. Maternal sitagliptin treatment attenuates offspring glucose metabolism and intestinal proinflammatory cytokines IL-6 and TNF-α expression in male rats , 2020, PeerJ.
[10] D. Drucker,et al. Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease , 2020, Molecular metabolism.
[11] A. Giusti-Paiva,et al. Neonatal overnutrition programming impairs cholecystokinin effects in adult male rats. , 2020, The Journal of nutritional biochemistry.
[12] M. Selbach,et al. mRNAs, proteins and the emerging principles of gene expression control , 2020, Nature Reviews Genetics.
[13] Yao Li,et al. Sitagliptin improves functional recovery via GLP‐1R‐induced anti‐apoptosis and facilitation of axonal regeneration after spinal cord injury , 2020, Journal of cellular and molecular medicine.
[14] J. Holst,et al. GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists , 2020, The Journal of clinical endocrinology and metabolism.
[15] A. Galli,et al. A novel mouse model of glucagon‐like peptide‐1 receptor expression: A look at the brain , 2020, The Journal of comparative neurology.
[16] Q. Zeng,et al. Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes , 2020, Frontiers in Endocrinology.
[17] K. Elkind-Hirsch,et al. Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study. , 2020, Journal of diabetes and its complications.
[18] Bing Yao,et al. Developmental changes and sex differences in DNA methylation and demethylation in hypothalamic regions of the mouse brain , 2020, Epigenetics.
[19] S. Omar,et al. Serum Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) in association with the Risk of Gestational Diabetes: A Prospective Case-Control Study , 2020, Journal of diabetes research.
[20] Chengcong Chen,et al. The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[21] G. Yeo,et al. Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake , 2019, Cell metabolism.
[22] K. Conrad,et al. Cholecystokinin, gastrin, cholecystokinin/gastrin receptors, and bitter taste receptor TAS2R14: trophoblast expression and signaling. , 2019, American journal of physiology. Regulatory, integrative and comparative physiology.
[23] V. Gurevich,et al. GPCR Signaling Regulation: The Role of GRKs and Arrestins , 2019, Front. Pharmacol..
[24] F. Reimann,et al. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism , 2019, Nature Reviews Endocrinology.
[25] D. Bates,et al. Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models , 2018, Science Translational Medicine.
[26] James E. Richards,et al. Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food , 2018, Diabetes.
[27] N. Irwin,et al. Novel dual incretin agonist peptide with antidiabetic and neuroprotective potential , 2018, Biochemical pharmacology.
[28] D. Drucker. Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1. , 2018, Cell metabolism.
[29] Casper Bo Jensen,et al. Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization , 2018, Endocrinology.
[30] David N. Groff,et al. Neonatal GLP1R activation limits adult adiposity by durably altering hypothalamic architecture , 2017, Molecular metabolism.
[31] Simon C. Cork,et al. Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain , 2015, Molecular metabolism.
[32] N. Šestan,et al. Functional Synergy between Cholecystokinin Receptors CCKAR and CCKBR in Mammalian Brain Development , 2015, PloS one.
[33] T. Hansen,et al. Incretin and glucagon levels in adult offspring exposed to maternal diabetes in pregnancy. , 2015, The Journal of clinical endocrinology and metabolism.
[34] K. Rácz,et al. Cord serum dipeptidyl‐peptidase 4 activity in gestational diabetes , 2015, European journal of clinical investigation.
[35] M. Sander,et al. Postnatal β-Cell Proliferation and Mass Expansion Is Dependent on the Transcription Factor Nkx6.1 , 2014, Diabetes.
[36] D. Drucker,et al. Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors , 2014, Endocrine reviews.
[37] B. Kuster,et al. Mass-spectrometry-based draft of the human proteome , 2014, Nature.
[38] Mingfeng Li,et al. Laminar and temporal expression dynamics of coding and noncoding RNAs in the mouse neocortex. , 2014, Cell reports.
[39] J. Nielsen,et al. Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.
[40] J. Nielsen,et al. Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics* , 2013, Molecular & Cellular Proteomics.
[41] N. Murakami,et al. Changes in mRNA expression of arcuate nucleus appetite-regulating peptides during lactation in rats , 2013, Journal of molecular endocrinology.
[42] N. Irwin,et al. Alterations of Glucose-Dependent Insulinotropic Polypeptide and Expression of Genes Involved in Mammary Gland and Adipose Tissue Lipid Metabolism during Pregnancy and Lactation , 2013, PloS one.
[43] Yuichiro Yamada,et al. Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor‐deficient mice , 2013, Journal of diabetes investigation.
[44] T. Vilsbøll,et al. Reduced postprandial GLP‐1 responses in women with gestational diabetes mellitus , 2013, Diabetes, obesity & metabolism.
[45] K. Blomgren,et al. Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species , 2013, Progress in Neurobiology.
[46] M. Ikeda,et al. Functional Compensation between Cholecystokinin-1 and -2 Receptors in Murine Paraventricular Nucleus Neurons* , 2012, The Journal of Biological Chemistry.
[47] A. C. Magalhães,et al. Regulation of GPCR activity, trafficking and localization by GPCR‐interacting proteins , 2012, British journal of pharmacology.
[48] S. Bouret,et al. Distinct Roles for Specific Leptin Receptor Signals in the Development of Hypothalamic Feeding Circuits , 2012, The Journal of Neuroscience.
[49] R. Parenti,et al. Gastric inhibitory polypeptide and its receptor are expressed in the central nervous system and support neuronal survival. , 2011, Central nervous system agents in medicinal chemistry.
[50] C. Hölscher,et al. Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis. , 2011, Journal of neurophysiology.
[51] K. Nakashima,et al. Epigenetic regulation in neural stem cell differentiation , 2010, Development, growth & differentiation.
[52] T. Matsui,et al. Cholecystokinin Facilitates Glutamate Release by Increasing the Number of Readily Releasable Vesicles and Releasing Probability , 2010, The Journal of Neuroscience.
[53] S. Chu,et al. Prepregnancy Obesity Prevalence in the United States, 2004–2005 , 2009, Maternal and Child Health Journal.
[54] M. Horowitz,et al. Role of cholecystokinin in appetite control and body weight regulation , 2005, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[55] S. Bouret,et al. Trophic Action of Leptin on Hypothalamic Neurons That Regulate Feeding , 2004, Science.
[56] S. Bouret,et al. Formation of Projection Pathways from the Arcuate Nucleus of the Hypothalamus to Hypothalamic Regions Implicated in the Neural Control of Feeding Behavior in Mice , 2004, The Journal of Neuroscience.
[57] N. Greig,et al. A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. , 2002, The Journal of pharmacology and experimental therapeutics.
[58] W. Rohde,et al. Cholecystokinin-8S levels in discrete hypothalamic nuclei of weanling rats exposed to maternal protein malnutrition , 1999, Regulatory Peptides.
[59] J. Flier,et al. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. Implications for energy homeostasis and neuroendocrine function. , 1998, The Journal of clinical investigation.
[60] S. Vigna,et al. Gastric inhibitory polypeptide (GIP) binding sites in rat brain , 1994, Peptides.
[61] M. Brownstein,et al. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. , 1993, Endocrinology.
[62] E. Van Obberghen,et al. Expression of IGF‐I and insulin receptor genes in the rat central nervous system: A developmental, regional, and cellular analysis , 1991, Journal of neuroscience research.
[63] K. Bremme,et al. Plasma Levels of Cholecystokinin and Gastrin During the Menstrual Cycle and Pregnancy , 1990, Acta obstetricia et gynecologica Scandinavica.
[64] A. Trzeciak,et al. Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[65] M. Raizada,et al. Insulin Binding in Four Regions of the Developing Rat Brain , 1984, Journal of neurochemistry.
[66] J. Peña,et al. Serum gastrin levels during pregnancy. , 1980, Revista espanola de fisiologia.
[67] P. Insel,et al. Detection of GPCR mRNA Expression in Primary Cells Via qPCR, Microarrays, and RNA-Sequencing. , 2021, Methods in molecular biology.